DNA and genomic profiling kits market seen reaching $2.09 billion by 2030

The Business Research Company says the global DNA and genomic profiling kits market is on track for steady growth through 2030, driven by precision medicine, genomic testing demand and broader use in diagnostics. North America led the market in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - DNA and genomic profiling kits are becoming central tools for genetic research, forensic analysis and medical diagnostics. - The market’s growth reflects stronger demand for precision medicine, cancer testing and broader genomic research. - The forecast points to expanding use of these kits across clinical and research settings through 2030.

What happened: - The Business Research Company released its Deoxyribonucleic Acid (DNA) and Genomic Profiling Kits Market Report 2026. - The report says the global market will rise from $1.28 billion in 2025 to $1.41 billion in 2026. - The report projects the market will reach $2.09 billion by 2030. - The report forecasts a 10.3% compound annual growth rate through 2030. - The report was published July 1, 2026. - The release was issued from London.

The details: - DNA and genomic profiling kits include reagents, consumables and assay components used to analyze genetic material and detect specific DNA sequences or variations. - The kits support DNA extraction, amplification, sequencing preparation and genetic marker identification. - The report links near-term growth to rising demand for genetic disorder screening, more forensic DNA profiling, greater use in cancer diagnostics and precision medicine, genomic research growth and improvements in PCR and sequencing methods. - The 2030 forecast is driven by investment in personalized medicine, demand for high-throughput genomic testing, expanding pharmacogenomics, wider use of bioinformatics and cloud-based genomic tools, and more genomic profiling for infectious disease monitoring. - The report highlights rapid DNA extraction kits, next-generation sequencing library preparation kits, multiplex PCR-based profiling assays, mutation detection kits in clinical diagnostics and single-sample testing kits as key trends. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The market story is being shaped by medicine moving toward more individualized treatment decisions. - The National Cancer Institute projected 2,001,140 new cancer cases in the U.S. in 2024, up from 1,958,310 in 2023, with 611,720 expected cancer-related deaths. - Those cancer numbers underscore why genomic profiling remains closely tied to oncology and precision diagnostics. - North America held the largest market share in 2025, reflecting advanced healthcare infrastructure and strong research activity. - Asia-Pacific is expected to be the fastest-growing region, supported by higher healthcare investment, expanding genomic research and growing awareness of personalized medicine. - The report also covers South East Asia, Western Europe, Eastern Europe, South America and the Middle East and Africa.

What's next: - The market is expected to keep expanding as more healthcare systems adopt genomics-driven testing and personalized medicine workflows. - The report says demand should continue to build around faster testing, broader sequencing applications and more cloud-based analysis tools. - Regional competition is likely to intensify as Asia-Pacific grows faster and North America retains scale.

The bottom line: - DNA and genomic profiling kits are moving from specialized research tools to mainstream diagnostics infrastructure, with growth set to stay strong through 2030.